Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) Receivables - Other (2017 - 2024)

Historic Receivables - Other for Mesoblast (MESO) over the last 3 years, with Q2 2019 value amounting to $1.5 million.

  • Mesoblast's Receivables - Other rose 14390.24% to $1.5 million in Q2 2019 from the same period last year, while for Jun 2019 it was $1.5 million, marking a year-over-year increase of 14390.24%. This contributed to the annual value of $1.5 million for FY2019, which is 14390.24% up from last year.
  • Per Mesoblast's latest filing, its Receivables - Other stood at $1.5 million for Q2 2019, which was up 14390.24% from $242000.0 recorded in Q3 2018.
  • Mesoblast's 5-year Receivables - Other high stood at $1.5 million for Q2 2019, and its period low was $196000.0 during Q3 2017.
  • Moreover, its 3-year median value for Receivables - Other was $698000.0 (2017), whereas its average is $818000.0.
  • Its Receivables - Other has fluctuated over the past 5 years, first plummeted by 1189.11% in 2018, then skyrocketed by 14390.24% in 2019.
  • Quarter analysis of 3 years shows Mesoblast's Receivables - Other stood at $1.5 million in 2017, then tumbled by 83.49% to $242000.0 in 2018, then soared by 519.83% to $1.5 million in 2019.
  • Its Receivables - Other was $1.5 million in Q2 2019, compared to $242000.0 in Q3 2018 and $615000.0 in Q2 2018.